FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38728111000001103: Bempedoic acid (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479571000001114 Bempedoic acid en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    1479581000001111 Bempedoic acid (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Bempedoic acid Is a Antilipemic agent false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Bempedoic acid 180mg tablets Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier
    Bempedoic acid 180mg / Ezetimibe 10mg tablets Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier
    Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier
    Nustendi 180mg/10mg tablets (Daiichi Sankyo UK Ltd) Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier
    Nilemdo 180mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier
    Bempedoic acid 180mg / Ezetimibe 10mg tablets 28 tablet Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier
    Bempedoic acid 180mg tablets 28 tablet Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier
    Nustendi 180mg/10mg tablets (Daiichi Sankyo UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient False Bempedoic acid Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start